45 reports of this reaction
2.0% of all DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE reports
#9 most reported adverse reaction
PNEUMONIA is the #9 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, manufactured by Major Pharmaceuticals. There are 45 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE to PNEUMONIA. This represents approximately 2.0% of all 2,218 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 45 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.0% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, making it a notable side effect.
If you experience pneumonia while taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.